Table of Contents Author Guidelines Submit a Manuscript
International Journal of Chronic Diseases
Volume 2015 (2015), Article ID 152616, 6 pages
http://dx.doi.org/10.1155/2015/152616
Research Article

Mean Platelet Volume and Splenomegaly as Useful Markers of Subclinical Activity in Egyptian Children with Familial Mediterranean Fever: A Cross-Sectional Study

1Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo 11562, Egypt
2Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo 11562, Egypt
3Department of Rheumatology, Faculty of Medicine, Cairo University, Cairo 11562, Egypt

Received 8 June 2015; Revised 27 June 2015; Accepted 5 July 2015

Academic Editor: Sulaiman M. Al-Mayouf

Copyright © 2015 Huda Marzouk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. T. Cassidy and R. E. Petty, “Periodic fever syndromes in children,” in Textbook of Pediatric Rheumatology, J. T. Cassidy and R. E. Petty, Eds., pp. 657–690, Elsevier, Philadelphia, Pa, USA, 5th edition, 2005. View at Google Scholar
  2. C. Fonnesu, C. Cerquaglia, M. Giovinale et al., “Familial Mediterranean fever: a review for clinical management,” Joint Bone Spine, vol. 76, no. 3, pp. 227–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Ben-Zvi and A. Livneh, “Chronic inflammation in FMF: markers, risk factors, outcomes and therapy,” Nature Reviews Rheumatology, vol. 7, no. 2, pp. 105–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Gershoni-Baruch, M. Shinawi, K. Leah, K. Badarnah, and R. Brik, “Familial mediterranean fever: prevalence, penetrance and genetic drift,” European Journal of Human Genetics, vol. 9, no. 8, pp. 634–637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. H. J. Lachmann, B. Şengül, T. U. Yavuzşen et al., “Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations,” Rheumatology, vol. 45, no. 6, pp. 746–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Notarnicola, M. N. Didelot, F. Seguret, J. Demaille, and I. Touitou, “Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever,” Genes and Immunity, vol. 3, no. 1, pp. 43–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Colak, B. Gurlek, Z. A. Yegin et al., “The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial Mediterranean fever,” Renal Failure, vol. 30, no. 2, pp. 187–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Dursun, F. Gok, O. Babacan et al., “Are mean platelet volume and splenomegaly subclinical inflammatory marker in children with familial Mediterranean fever?” Health, vol. 2, no. 7, pp. 692–695, 2010. View at Publisher · View at Google Scholar
  9. D. Aharoni, N. Hiller, and I. Hadas-Halpern, “Familial Mediterranean fever: abdominal imaging findings in 139 patients and review of the literature,” Abdominal Imaging, vol. 25, no. 3, pp. 297–300, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Rimon, Y. Meir, and L. Cohen, “Retroperitoneal lymphadenopathy in familial Mediterranean fever,” Postgraduate Medical Journal, vol. 65, no. 768, pp. 776–778, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Y. Gasparyan, L. Ayvazyan, D. P. Mikhailidis, and G. D. Kitas, “Mean platelet volume: a link between thrombosis and inflammation?” Current Pharmaceutical Design, vol. 17, no. 1, pp. 47–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Endler, A. Klimesch, H. Sunder-Plassmann et al., “Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease,” British Journal of Haematology, vol. 117, no. 2, pp. 399–404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Bath, C. Algert, N. Chapman, and B. Neal, “Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease,” Stroke, vol. 35, no. 3, pp. 622–626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Y. Gasparyan, A. Sandoo, A. Stavropoulos-Kalinoglou, and G. D. Kitas, “Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy,” Rheumatology International, vol. 30, no. 8, pp. 1125–1129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Kisacik, A. Tufan, U. Kalyoncu et al., “Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis,” Joint Bone Spine, vol. 75, no. 3, pp. 291–294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Yüksel, K. Helvacı, Ö. BaŞar et al., “An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume,” Platelets, vol. 20, no. 4, pp. 277–281, 2009. View at Publisher · View at Google Scholar
  17. S. Sahin, S. Senel, H. Ataseven, and I. Yalcin, “Does mean platelet volume influence the attack or attack-free period in patients with familial Mediterranean fever?” Platelets, vol. 24, no. 4, pp. 320–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Bilginer, F. Ozaltin, C. Basaran et al., “Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis,” Rheumatology International, vol. 28, no. 12, pp. 1211–1216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Makay, Z. Türkyilmaz, and E. Ünsal, “Mean platelet volume in children with familial Mediterranean fever,” Clinical Rheumatology, vol. 28, no. 8, pp. 975–978, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Arica, C. Özer, V. Arica, A. Karakuş, T. Çelik, and R. Güneşaçar, “Evaluation of the mean platelet volume in children with familial Mediterranean fever,” Rheumatology International, vol. 32, no. 11, pp. 3559–3563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Coban and H. Adanir, “Platelet activation in patients with Familial Mediterranean fever,” Platelets, vol. 19, no. 6, pp. 405–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Livneh, P. Langevitz, D. Zemer et al., “Criteria for the diagnosis of familial Mediterranean fever,” Arthritis & Rheumatism, vol. 40, no. 10, pp. 1879–1885, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Yalçinkaya, S. Özen, Z. B. Özçakar et al., “A new set of criteria for the diagnosis of familial Mediterranean fever in childhood,” Rheumatology, vol. 48, no. 4, pp. 395–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. Ö. L. Konuş, A. Özdemir, A. Akkaya, G. Erbaş, H. Çelik, and S. Işik, “Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography,” The American Journal of Roentgenology, vol. 171, no. 6, pp. 1693–1698, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Diaz-Ricart, L. Brunso, M. Pino et al., “Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters,” Thrombosis Research, vol. 126, no. 1, pp. e30–e35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Bimpong and J. Burthem, “Supplementary techniques including blood parasite diagnosis,” in Dacie and Lewis Practical Haematology, B. J. Bain, I. Bates, M. A. Laffan, and S. M. Lewis, Eds., p. 102, Elsevier, 11th edition, 2012. View at Google Scholar
  27. A. Inal, M. Yilmaz, S. G. Kendirli, D. U. Altintas, and G. B. Karakoc, “The clinical and genetical features of 124 children with Familial Mediterranean fever: experience of a single tertiary center,” Rheumatology International, vol. 29, no. 11, pp. 1279–1285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. I. K. Paut, M. Dubuc, J. Sportouch, P. Minodier, J. M. Garnier, and I. Touitou, “Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucou features,” Rheumatology, vol. 39, no. 11, pp. 1275–1279, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Yazici, M. Yazici, B. Erer et al., “The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity,” Platelets, vol. 21, no. 2, pp. 122–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Yazici, M. Yazici, B. Erer et al., “The platelet functions in patients with ankylosing spondylitis: anti-TNF-α therapy decreases the mean platelet volume and platelet mass,” Platelets, vol. 21, no. 2, pp. 126–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Kaser, G. Brandacher, W. Steurer et al., “Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis,” Blood, vol. 98, no. 9, pp. 2720–2725, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Clarke, P. W. M. Johnson, R. E. Banks et al., “Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood,” Cytokine, vol. 8, no. 9, pp. 717–723, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. M. M. Van Gameren, P. H. B. Willemse, N. H. Mulder et al., “Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study,” Blood, vol. 84, no. 5, pp. 1434–1441, 1994. View at Google Scholar · View at Scopus
  34. A. Akdogan, M. Calguneri, B. Yavuz et al., “Are Familial Mediterranean Fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF,” Journal of the American College of Cardiology, vol. 48, no. 11, pp. 2351–2353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Caliskan, H. Gullu, S. Yilmaz et al., “Impaired coronary microvascular function in familial Mediterranean fever,” Atherosclerosis, vol. 195, no. 2, pp. e161–e167, 2007. View at Publisher · View at Google Scholar · View at Scopus